Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Virol ; 91(18)2017 09 15.
Article in English | MEDLINE | ID: mdl-28659487

ABSTRACT

The mumps virus (MuV) small hydrophobic protein (SH) is a type I membrane protein expressed in infected cells. SH has been reported to interfere with innate immunity by inhibiting tumor necrosis factor alpha (TNF-α)-mediated apoptosis and NF-κB activation. To elucidate the underlying mechanism, we generated recombinant MuVs (rMuVs) expressing the SH protein with an N-terminal FLAG epitope or lacking SH expression due to the insertion of three stop codons into the SH gene. Using these viruses, we were able to show that SH reduces the phosphorylation of IKKß, IκBα, and p65 as well as the translocation of p65 into the nucleus of infected A549 cells. Reporter gene assays revealed that SH interferes not only with TNF-α-mediated NF-κB activation but also with IL-1ß- and poly(I·C)-mediated NF-κB activation, and that this inhibition occurs upstream of the NF-κB pathway components TRAF2, TRAF6, and TAK1. Since SH coimmunoprecipitated with tumor necrosis factor receptor 1 (TNFR1), RIP1, and IRAK1, we hypothesize that SH exerts its inhibitory function by interacting with TNFR1, interleukin-1 receptor type 1 (IL-1R1), and TLR3 complexes in the plasma membrane of infected cells.IMPORTANCE The MuV SH has been shown to impede TNF-α-mediated NF-κB activation and is therefore thought to contribute to viral immune evasion. However, the mechanisms by which SH mediates NF-κB inhibition remained largely unknown. In this study, we show that SH interacts with TNFR1, IL-1R1, and TLR3 complexes in infected cells. We thereby not only shed light on the mechanisms of SH-mediated NF-κB inhibition but also reveal that SH interferes with NF-κB activation induced by interleukin-1ß (IL-1ß) and double-stranded RNA.


Subject(s)
Host-Pathogen Interactions , Mumps virus/immunology , NF-kappa B/antagonists & inhibitors , Receptors, Tumor Necrosis Factor, Type I/metabolism , Toll-Like Receptor 3/metabolism , Viral Proteins/metabolism , Animals , Cell Line , Humans , Receptors, Interleukin-1 Type I
2.
Regul Toxicol Pharmacol ; 73(2): 494-500, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26399164

ABSTRACT

Pyrrolizidine alkaloids (PA) are common plantal toxins directed against insect herbivores. Unsaturated PAs are known to be hepatotoxic. Many of the PAs are in addition mutagenic and some may possibly be carcinogenic for humans. The risk of an exposure to PAs associated with their occurrence in herbal medicinal products and in foodstuff is under current discussion. The present risk assessment for herbal medicinal products containing PAs is based on a margin of safety derivation for foodstuff indicating that a life-long exposure to maximally 0.007 µg/kg bw/day is not expected to be associated with safety concerns. This approach offers a possibility to estimate the potential risk of PA-containing herbal medicinal products irrespective of the route of administration. It assumes PA levels in the final herbal medicinal product below 0.01 ppm and considers for dermal administration a 100% skin penetration of the PAs reflecting a worst-case scenario. As a result, the calculated margins of safety show a potential exposure using herbal medicinal products 70-, 45.5-, and 19.3-fold lower on a one-day base and 608-, 396-, and 168- fold lower on a one-year base for adults, children aged 12 years, and children aged 4 years, respectively, than the thresholds considered acceptable for foodstuff.


Subject(s)
Food/adverse effects , Phytotherapy/adverse effects , Plants, Medicinal/adverse effects , Pyrrolizidine Alkaloids/adverse effects , Adult , Child , Child, Preschool , Environmental Exposure/adverse effects , Environmental Exposure/standards , Female , Humans , Male , Phytotherapy/standards , Risk Assessment/methods
3.
Avian Dis ; 57(3): 612-21, 2013 Sep.
Article in English | MEDLINE | ID: mdl-24283126

ABSTRACT

Molecular characterization studies of a diverse collection of avian influenza viruses (AIVs) have demonstrated that AIVs' greatest genetic variability lies in the HA, NA, and NS genes. The objective here was to quantify the association between geographical locations, periods of time, and host species and pairwise nucleotide variation in the HA, NA, and NS genes of 70 isolates of H5N1 highly pathogenic avian influenza virus (HPAIV) collected from October 2005 to December 2007 from birds in Romania. A mixed-binomial Bayesian regression model was used to quantify the probability of nucleotide variation between isolates and its association with space, time, and host species. As expected for the three target genes, a higher probability of nucleotide differences (odds ratios [ORs] > 1) was found between viruses sampled from places at greater geographical distances from each other, viruses sampled over greater periods of time, and viruses derived from different species. The modeling approach in the present study maybe useful in further understanding the molecular epidemiology of H5N1 HPAI virus in bird populations. The methodology presented here will be useful in predicting the most likely genetic distance for any of the three gene segments of viruses that have not yet been isolated or sequenced based on space, time, and host species during the course of an epidemic.


Subject(s)
Genetic Variation , Hemagglutinin Glycoproteins, Influenza Virus/genetics , Influenza A Virus, H5N1 Subtype/genetics , Molecular Epidemiology/methods , Neuraminidase/genetics , Viral Nonstructural Proteins/genetics , Viral Proteins/genetics , Animals , Bayes Theorem , Birds , Geography , Hemagglutinin Glycoproteins, Influenza Virus/metabolism , Influenza A Virus, H5N1 Subtype/metabolism , Influenza in Birds/virology , Models, Theoretical , Neuraminidase/metabolism , Regression Analysis , Romania , Sequence Analysis, RNA/veterinary , Species Specificity , Time Factors , Viral Nonstructural Proteins/metabolism , Viral Proteins/metabolism
4.
J Gen Virol ; 93(Pt 10): 2118-2130, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22815272

ABSTRACT

Recent RNA interference (RNAi) studies have identified many host proteins that modulate virus infection, but small interfering RNA 'off-target' effects and the use of transformed cell lines limit their conclusiveness. As murine embryonic stem (mES) cells can be genetically modified and resources exist where many and eventually all known mouse genes are insertionally inactivated, it was reasoned that mES cells would provide a useful alternative to RNAi screens. Beyond allowing investigation of host-pathogen interactions in vitro, mES cells have the potential to differentiate into other primary cell types, as well as being used to generate knockout mice for in vivo studies. However, mES cells are poorly characterized for virus infection. To investigate whether ES cells can be used to explore host-virus interactions, this study characterized the responses of mES cells following infection by herpes simplex virus type 1 (HSV-1) and influenza A virus. HSV-1 replicated lytically in mES cells, although mES cells were less permissive than most other cell types tested. Influenza virus was able to enter mES cells and express some viral proteins, but the replication cycle was incomplete and no infectious virus was produced. Knockdown of the host protein AHCYL1 in mES cells reduced HSV-1 replication, showing the potential for using mES cells to study host-virus interactions. Transcriptional profiling, however, indicated the lack of an efficient innate immune response in these cells. mES cells may thus be useful to identify host proteins that play a role in virus replication, but they are not suitable to determine factors that are involved in innate host defence.


Subject(s)
Embryonic Stem Cells/physiology , Embryonic Stem Cells/virology , Influenza A virus/physiology , Orthomyxoviridae Infections/genetics , Virus Replication/genetics , Animals , Cell Line , Cricetinae , DNA Replication/genetics , Dogs , Embryonic Stem Cells/metabolism , HeLa Cells , Herpes Simplex/genetics , Herpes Simplex/metabolism , Herpesvirus 1, Human/genetics , Herpesvirus 1, Human/metabolism , Herpesvirus 1, Human/physiology , Host-Pathogen Interactions , Humans , Influenza A virus/genetics , Influenza A virus/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Orthomyxoviridae Infections/metabolism , Orthomyxoviridae Infections/virology , RNA, Small Interfering/genetics , Transcription, Genetic , Viral Proteins/genetics , Viral Proteins/metabolism
5.
Regul Toxicol Pharmacol ; 61(3): 261-75, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21889559

ABSTRACT

Thousands of drugs are currently in use, but only for a few of them experimental chronic fish data exist. Therefore, Huggett et al. (Human Ecol Risk Assess 2003; 9:1789-1799) proposed the fish plasma model (FPM) to extrapolate the potential of unintended long-term effects in fish. The FPM compares human therapeutic plasma concentrations (HPC(T)) with estimated fish steady-state concentrations (FPC(ss)), under the assumption that biological drug targets may be conserved across the species. In this study, the influence of using different input parameters on the model result was characterised for 42 drugs. The existence of structurally and functionally conserved protein targets in zebrafish could not be refuted. Thus, the FPM model application was not in contradiction to its basic assumption. Further, dissociation of drugs was shown to be important in determining the output and model robustness. As the proposed model for FPC(ss) estimation was considered to predict accurate values for neutral and lipophilic chemicals only, a modified bioconcentration model was used with D(OW) as predictor. Using reasonable worst case assumptions, a hazard was indicated for one third of the selected drugs. Our results support the notion that this approach might help to prioritise among in use drugs to identify compounds where follow up evidence should be considered.


Subject(s)
Drug-Related Side Effects and Adverse Reactions , Models, Theoretical , Pharmaceutical Preparations/blood , Zebrafish , 1-Octanol/chemistry , Animals , Area Under Curve , Humans , Hydrophobic and Hydrophilic Interactions , Pharmaceutical Preparations/metabolism , Pharmacokinetics , Proteins/metabolism , Risk Assessment/methods , Water/chemistry
6.
Aquat Toxicol ; 90(2): 102-8, 2008 Nov 11.
Article in English | MEDLINE | ID: mdl-18824267

ABSTRACT

Differential sensitivities of microalgae to triclosan have been reported, which may have significant implications for environmental risk assessment of this widely used biocide. Therefore, the aim of this study was to derive a mechanistic understanding of varying microalgal sensitivity to this substance. The toxicity of triclosan was evaluated using microalgal systems varying in biological complexity, exposure time and systematic position (a synchronized culture of the chlorophyte Scenedesmus vacuolatus, a diatom Nitzschia palea cultivated in suspension as well as attached to surfaces and periphyton communities). The results revealed (1) differences in sensitivity of the selected microalgal systems of three orders of magnitude and (2) highest sensitivity of the chlorophyte to triclosan in the range of environmental concentrations. To investigate algal sensitivity to triclosan in more detail, bioavailability was considered by investigating suspended and attached living algae. Differences in the generation time (in comparison to test duration) of the species were addressed by evaluating and modeling concentration-time-effect relationships. However, varying sensitivities of the selected microalgal systems remained unexplained. Comparison of species-specific toxic responses to calculated effect concentrations, derived from quantitative relationships for narcosis and uncoupling mode-of-action, leads us to the conclusion that triclosan may address multiple target sites in different microalgal species.


Subject(s)
Diatoms/drug effects , Scenedesmus/drug effects , Triclosan/toxicity , Water Pollutants, Chemical/toxicity , Biofilms/drug effects , Cell Proliferation/drug effects , Dose-Response Relationship, Drug , Photosynthesis/drug effects , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...